immatics biotechnologies GmbH (4A3) — Cash Flow Quality Index
immatics biotechnologies GmbH (4A3) has a Cash Flow Quality Index of -1.21x as of December 2024. Operating cash flow of €-58.48 Million is below net income of €48.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 4A3 total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
immatics biotechnologies GmbH Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for immatics biotechnologies GmbH across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is immatics biotechnologies GmbH's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for immatics biotechnologies GmbH (2022–2024)
Year-by-year earnings quality comparison for immatics biotechnologies GmbH. For live market cap and the full company financial profile, see immatics biotechnologies GmbH stock valuation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -9.63x | €-158.03 Million | €16.41 Million | ▼ -488.3% |
| 2022 | 2.48x | €100.13 Million | €40.38 Million | — |